Deep vein thrombosis and anticoagulant therapy.
This article focuses on deep vein thrombosis (DVT) and anticoagulant therapy. The risk factors, pathophysiology, prevention, and detection of DVT are explained. Anticoagulants such as unfractionated heparin (UFH), low molecular weight heparin (enoxaparin), and warfarin are discussed. The article also reviews nursing assessment and monitoring of patients with DVT as well as patient education on anticoagulants.
Sullano
M A
MA
Division of Nursing, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Ortiz
E J
EJ
D000925:Anticoagulants / Q000627:therapeutic use*; D004347:Drug Interactions; D006493:Heparin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D009730:Nursing Assessment; D012307:Risk Factors; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin